24/7 Patient Assistance: 760-405-8205
specialties & services
Dr. Sravana Chennupati is a radiation oncologist that currently lives and practices in Berkeley, California. He is certified by the American Board in radiation oncology and works at the moment at three medical institutions, OHSU Hospital, Alta Bates Summit Medical Center and Diablo Valley Oncology and Hematology Medical Group. Dr. Chennupati received his medical degree from Stanford University School of Medicine and has over 10 years of experience in the radiation oncology field. After he got his medical degree Dr. Chennupati went to Kaiser Permanente Medical Group and completed an internship in internal medicine. He finished his medical studies with a residency in radiation oncology at Oregon Health & Science University. Dr. Chennupati accepts the following insurances: Aetna, Cigna, MultiPlan, Blue Shield of California, Blue Cross of California, FirstHealth PPO.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOMultiPlan
Stanford University School of Medicine
Medical School
Kaiser Permanente Medical Group
Internship
Oregon Health & Science University
Residency
American Board of Radiology - Diagnostic Radiology
Alta Bates Summit Medical Center - Herrick Campus
Languages: English/Spanish
(510) 204-1591
2001 Dwight Way
Read MoreDiablo Valley Oncology and Hematology Medical Group
Languages: English/Spanish
(925) 677-5041
400 Taylor Blvd #202
Pleasant Hill, California 94523
Read MoreOHSU Hospital - Portland
Languages: English/Spanish
(503) 494-8311
3181 SW Sam Jackson Park Rd
Read MoreThe impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.
Son, C. H.,Chennupati, S. K.,Kunnavakkam, R.,Liauw, S. L.; Pract Radiat Oncol. 2014 Dec 11.
See more >>Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy.
Chennupati, S. K.,Pelizzari, C. A.,Kunnavakkam, R.,Liauw, S. L.; Cancer Med. 2014 May 08.
See more >>Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Chennupati, S. K.,Quon, A.,Kamaya, A.,Pai, R. K.,La, T.,Krakow, T. E.,Graves, E.,Koong, A. C.,Chang, D. T.; Am. J. Clin. Oncol.. 2011 Mar 23.
See more >>